Author:
LV Chen-Bin,Tong Lin-Yan,Zeng Wei-Ming,Chen Qiu-Xian,Fang Shun-Yong,Sun Yu-Qin,Cai Li-Sheng
Funder
PhD workstation at Zhangzhou Affiliated Hospital of Fujian Medical University
Startup Fund for Scientific Research at Fujian Medical University
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
2. Mokadem I, Dijksterhuis W, van Putten M, et al. Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a Multicenter Study. Gastric Cancer. 2019;22:1263–73.
3. Morgagni P, Bencivenga M, Carneiro F et al. International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape: Bertinoro Workshop, November 2022. Gastric Cancer. 2024 Apr 18.
4. Bhandare MS, Gundavda KK, Yelamanchi R, et al. Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: analysis of 1001 cases. Eur J Surg Oncol. 2024;50:108343.
5. Wang X, Lu C, Wei B, et al. Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial. J Hematol Oncol. 2024;17:17.